Navigation Links
Androgel Manufacturers Sued in Class Action for Antitrust Violations
Date:4/7/2009

LANCASTER, Pa., April 7 /PRNewswire-USNewswire/ -- A class action complaint filed last week in New Jersey federal court claims damages for violations of the Sherman Antitrust Act by brand-name and generic manufacturers of the drug, Androgel. The case, filed by Stephen L. LaFrance Pharmacy, Inc. d/b/a SAJ Distributors and Stephen L. LaFrance Holdings, Inc., names as Defendants Unimed Pharmaceuticals Inc., Solvay Pharmaceuticals Inc., Watson Pharmaceuticals Inc., Par Pharmaceuticals, Inc. and Paddock Laboratories, Inc.

Androgel is a testosterone replacement therapy for men who have a deficiency or absence of endogenous testosterone.

The lawsuit is a class action filed on behalf of all persons or entities that purchased Androgel directly from any defendant from at least January 1, 2006 until a date yet to be determined.

The suit alleges that the brand name and generic manufacturers conspired to fix and raise the price of Androgel, by overcharging Plaintiffs and others by millions of dollars and depriving them of cheaper generic versions of the drug. The complaint estimates that hundreds or thousands of people or companies have been economically injured by the drug manufacturers' conduct.

Two law firms have joined forces to litigate the class action: RodaNast, P.C. in Pennsylvania and the Roberts Law Firm in Arkansas.


'/>"/>
SOURCE RodaNast, P.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
2. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
3. DoD and VA Recognize Innovative Healthcare Manufacturers for Excellence in Supply Chain Data Quality
4. New BSI CE-Onsite Facilitates CE Marking Reviews for Device Manufacturers
5. Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors?
6. Chubb Named Preferred Insurance Provider for Medical Device Manufacturers
7. Grocery Manufacturers Association Statement Regarding President Obamas Nomination of FDA Commissioner
8. Alliance of Automobile Manufacturers to Participate in the National Federation of the Blind Motor City March for Independence
9. Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: JNJ, ABT, LLY, PFE, NVS, GSK
10. Grocery Manufacturers Association: National Brands of Jarred Peanut Butter Not Affected by PCA Recall, Many Food Products Unaffected by Peanut Corporation of America (PCA) Recall
11. China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: